Clinical Trials Browser

Unknown × Lymphoma, B-Cell, Marginal Zone × Bortezomib × Clear all

NCT04433156 2023-05-18

VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma

Phase 2 Unknown

Lymphoma, B-Cell, Marginal Zone

NCT03335098 2017-11-07

BOMB-THROW

Phase 2 Unknown

Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone